Journal list menu
- IssueVolume 103, Issue 6
Special Focus Issue: SLB Initiative – Negative Regulators of Inflammatory Signaling Cascades
985-1251June 2018
Export Citations
ISSUE INFORMATION
EDITORIAL
Commercial scale production of RvD4 opens the resolving door to new research
- Pages: 991-993
- First Published: 30 March 2018
Treatment with exogenous RvD4 reveals pro-resolving actions and suggests future therapies for treatment of acute inflammatory diseases.
SPOTLIGHT ON LEADING EDGE RESEARCH
Frontline Science: Structural insights into Resolvin D4 actions and further metabolites via a new total organic synthesis and validation
- Pages: 995-1010
- First Published: 29 January 2018
Resolvin D4 commercial-scale total organic synthesis elucidates new functions.
REVIEWS
pTRAPs: Transmembrane adaptors in innate immune signaling
- Pages: 1011-1019
- First Published: 30 March 2018
Review on palmitoylated transmembrane adaptor family members as protein scaffolds and signaling regulators in innate immunity.
The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk
- Pages: 1021-1028
- First Published: 30 March 2018
Small transition along the monocyte continuum better reflects cardiovascular risk than a simplified analysis of monocyte subsets based on expression of the surface antigens CD14/CD16.
SPECIAL FOCUS ISSUE
REVIEWS
Role of negative regulation of immune signaling pathways in neutrophil function
- Pages: 1029-1041
- First Published: 19 December 2017
Review on how PMN functions are negatively regulated by immune signaling pathways.
Truncation of neurokinin-1 receptor—Negative regulation of substance P signaling
- Pages: 1043-1051
- First Published: 10 January 2018
The truncated isoform of the neurokinin 1 receptor generated through alternative splicing regulates several biologic functions which include immune and inflammation pathways.
SHIP negatively regulates type II immune responses in mast cells and macrophages
- Pages: 1053-1064
- First Published: 17 January 2018
Review on SHIP's role in mast cell and macrophage activation in vitro, in the SHIP−/− mouse, and human immune-mediated diseases.
The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function
- Pages: 1065-1076
- First Published: 22 January 2018
Review on the role of the PI3K/AKT pathway in regulatory T cell development and function, with a focus on pathologies associated with impaired PI3K signaling.
New revelations from an old receptor: Immunoregulatory functions of the inhibitory Fc gamma receptor, FcγRIIB (CD32B)
- Pages: 1077-1088
- First Published: 06 February 2018
Review of the canonical and non-canonical functions of FcγRIIB and its potential as a therapeutic target for immunotherapy of cancer and autoimmune disorders.
TRAF3 regulation of inhibitory signaling pathways in B and T lymphocytes by kinase and phosphatase localization
- Pages: 1089-1098
- First Published: 17 January 2018
Review of how TRAF3 both promotes and restrains inhibitory signaling to B and T lymphocytes by cytokine and antigen receptors.
Negative regulation of type I IFN signaling
- Pages: 1099-1116
- First Published: 22 January 2018
Review on the fine-tuning of IFN signaling by negative regulators of the IFN production and response.
Breaking self-tolerance during autoimmunity and cancer immunity: Myeloid cells and type I IFN response regulation
- Pages: 1117-1129
- First Published: 02 February 2018
Review of innate immune regulation in both cancer and autoimmune disease pathogenesis, with a focus on the function and regulation of type 1 IFN responses.
Modulating inflammation through the negative regulation of NF-κB signaling
- Pages: 1131-1150
- First Published: 01 February 2018
Review of regulators that negatively modulate NF-κB signaling to attenuate inflammation and promote resolution.
A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis
- Pages: 1151-1164
- First Published: 02 February 2018
Review of checkpoint proteins' contributions to immunological signaling in shock and sepsis.
An update on cell intrinsic negative regulators of the NLRP3 inflammasome
- Pages: 1165-1177
- First Published: 26 January 2018
Review on recent advances in our understanding of the mechanisms that negatively regulate NLRP3 inflammasome activation.
Negative regulators that mediate ocular immune privilege
- Pages: 1179-1187
- First Published: 12 February 2018
Review of key molecular and cellular negative regulators of inflammation within the immune privileged eye.
On taking the STING out of immune activation
- Pages: 1189-1195
- First Published: 12 February 2018
Review on STING's role and regulation in immunity against tumors and certain viruses.
Regulation of immune cell signaling by activated protein C
- Pages: 1197-1203
- First Published: 30 March 2018
Review on select leukocytic functions and how they are regulated by the anti-inflammatory protease, activated protein C.
miRNA regulation of innate immunity
- Pages: 1205-1217
- First Published: 14 April 2018
Review on role miRNAs in innate immunity as well as mechanistic pathways regulated by key miRNAs.
IFN-γ orchestrates tumor elimination, tumor dormancy, tumor escape, and progression
- Pages: 1219-1223
- First Published: 22 February 2018
Review on the mechanisms by which IFN-gamma manifests paradoxical functions of relevance to developing highly tailored immunotherapeutics for cancer patients.
PRIMARY RESEARCH
CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages
- Pages: 1225-1240
- First Published: 13 February 2018
USP18 promotes HIV-1 replication by negatively regulating expression of antiviral genes induced by T1 IFN signaling.
INFLAMMATION, EXTRACELLULAR MEDIATORS, & EFFECTOR MOLECULES
Protective effect of dihydromyricetin on LPS-induced acute lung injury
- Pages: 1241-1249
- First Published: 09 March 2018
The protective effect of DHM on ALI by regulating inflammation and the underlying mechanism identified by computational analysis and animal experiment.
LETTER TO EDITOR
Dr. Luigi (Gigi) Varesio: A memorial
- Pages: 1251
- First Published: 01 April 2018
Memorial tribute to Dr. Varesio's career and contributions to the field of leukocyte biology.